Pediatric COVID-19 monoclonal antibody (mAb) administration

In response to the increasing number of pediatric COVID-19 cases and the high-risk patient population served by providers at Kentucky Children’s Hospital, a need was identified in order to provide COVID-19 monoclonal antibody administration. A task force was instituted and has worked to draft and implement a workflow for COVID-19 monoclonal antibody administration for pediatric… Read More

Message from EVPHA Mark F. Newman, MD

As the number of COVID patients increases, operations must respond Colleagues: A word of thanks. You have been able to stand your ground during a once in a lifetime pandemic (we hope) and provide hope, healing and grace for our patients, their families and each other. No doubt, like the rest of us, you are… Read More

COVID-19 monoclonal antibody treatment now given as subcutaneous injections  

Providers can now order COVID-19 monoclonal antibody treatment and prophylaxis for adult patients who are at high risk for progression to severe COVID-19. UK HealthCare has transitioned adult outpatient monoclonal antibody IV infusions to subcutaneous injections. The new process, which is being offered at the UK Wellington Infusion Center on Wellington Way, consists of four… Read More

UK opens pediatric research program for children’s COVID-19 vaccine

In a media event today, it was announced UK has been selected as a site for KidCOVE, a national research study to ensure a safe and effective vaccine that protects children ages 6 months through 11 years from getting sick with COVID-19. Using the Moderna vaccine currently authorized for adults, this pediatric research study will… Read More